TALLAHASSEE, Fla. (WCTV) - The Food and Drug Administration is expected to soon decide if Florida can import cheaper ...
LONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial, a win for the company after the same drug produced ...
SYDNEY, Sept. 22 (Xinhua) -- Researchers from Australia's University of Queensland have identified a new drug target that has the potential to overcome drug resistance and prevent tumor regrowth ...
A drug from AstraZeneca Plc and Daiichi Sankyo Co. showed favorable results in a trial for a common type of breast cancer, in a sign it could become a top seller for the British pharmaceutical ...
An Israeli company that has a U.S. headquarters in Waltham said Monday it has received approval for a new drug for blood cancer. Biopharmaceutical company BioLineRx Ltd. (Nasdaq: BLRX) said the U ...
Sept 15 (Reuters) - (This Sept. 15 story has been corrected show that momelotinib is approved for patients regardless of prior myelofibrosis therapy, not just for patients previously treated ...
Add articles to your saved list and come back to them any time. A drug invented in Melbourne to treat a lethal bone marrow cancer is set to become a billion-dollar global blockbuster after US ...
What do you do when the country you rely on for your life-saving medicines is the one you consider your systemic rival? Every day, many tons of chemicals are churned out in Chinese factories, which ...
Merck & Co Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Wednesday the U.S. Food and Drug Administration (FDA) ...
The US Food and Drug Administration (FDA) has increased its collaboration with cancer drug manufacturers in a bid to overcome the country’s ongoing drug shortage problem and reduce impacts on patients ...
Cosmetics sales in China are soaring, but a group of exporting nations led by France are pushing Beijing to lift restrictions they say are blocking them unfairly. By Keith Bradsher and Elizabeth ...
Cancer experts have made two calls for action from US lawmakers this year: fix the ongoing cancer drug shortage, and increase funding for cancer research. The American Association for Cancer ...